Project IVAC-ALL-1

Basic data

Title:
IVAC-ALL-1
Duration:
01/10/2016 to 31/12/2018
Abstract / short description:
Prospective phase I/II study: Patient-individualized peptide vaccination based on whole exome sequencing with adjuvant GM-CSF in children with relapsed acute lymphoblastic leukemia

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen

Local organizational units

University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes
Faculty of Medicine

Funders

Heidelberg, Baden-Württemberg, Germany
Help

will be deleted permanently. This cannot be undone.